Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.36 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
| ▸ | ATR | Q13535 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19255526 | 0.86 | CYP4F2 (0.38) | CYP4F2CYP4A11RETATRLMNA | |
| SCHEMBL19250639 | 0.83 | CYP4F2 (0.38) | CYP4F2CYP4A11RETATRLMNA | |
| SCHEMBL26926725 | 0.82 | CYP4F2 (0.38) | CYP4F2CYP4A11RETLMNAESR1 | |
| SCHEMBL19204872 | 0.82 | CYP4F2 (0.40) | CYP4F2CYP4A11RETATRLMNA | |
| SCHEMBL30242675 | 0.82 | CYP4F2 (0.47) | CYP4F2CYP4A11LMNAESR1MAPT | |
| SCHEMBL24012790 | 0.82 | CYP4F2 (0.47) | CYP4F2CYP4A11LMNAESR1MAPT | |
| SCHEMBL19204837 | 0.82 | CYP4F2 (0.38) | CYP4F2CYP4A11RETLMNAESR1 | |
| SCHEMBL30673093 | 0.82 | CYP4F2 (0.38) | CYP4F2CYP4A11RETLMNAESR1 | |
| SCHEMBL18370833 | 0.79 | ATR (0.36) | CYP4F2CYP4A11RETATRLMNA | |
| SCHEMBL18371315 | 0.78 | RET (0.36) | CYP4F2CYP4A11RETATRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017133667-A1 | PYRIMIDINE AND PYRIDINE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017133670-A1 | PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA | SAVIRA PHARMACEUTICALS GMBH (AT) | 2017-08-10 | — | — | WO | disclosed |